Filtering

Page: () 1 2 3 4 5 6 7 8 9 10 ()
ECCO'17 BarcelonaThe long-term safety outside clinical trials
Year: 2017
Source: ECCO'17 Barcelona
Authors: van Assche G.
Last Modified: Wednesday, 15 March 2017, 2:50 PM by ECCO Administrator
Post operative complications, IBD in the elderly, IBD and malignancy
Files: 1
ECCO'17 BarcelonaThe patient with psychological comorbidities: How to wean off opiates in these patients? Is there any preference in drugs?
Year: 2017
Source: ECCO'17 Barcelona
Authors: Andrews J.
Last Modified: Wednesday, 15 March 2017, 2:18 PM by ECCO Administrator
Psychologist, Psychologic comorbidity, Anxiety, Depression, Coping
Files: 1
ECCO'17 BarcelonaThe use of IBD medicine in patients with cancer: Which treatment should be stopped when cancer is diagnosed? Which treatment to use in a patient with a prior diagnosis with cancer?
Year: 2017
Source: ECCO'17 Barcelona
Authors: Beaugerie L.
Last Modified: Wednesday, 15 March 2017, 2:05 PM by ECCO Administrator
5-ASA, Anti-TNF agents, Thiopurines ( AZA / MP )
Files: 1
15th IBD Intensive Advanced CourseThiopurines
Year: 2017
Source: 15th IBD Intensive Advanced Course
Authors: Irving P.
Last Modified: Wednesday, 15 March 2017, 1:16 PM by Vesna Babaja
Pharmacogenetics,Pharmacokinetics, Thiopurines (AZA/MP)
Files: 1
Webcast - ECCO 2016 Amsterdam Congress - 9th Y-ECCO Career Workshop : Session 2: Group session - Reviewing a scientific paper (Keywords: ECCO)Tips, tricks and pitfalls for peer reviewers
Source: Webcast - ECCO 2016 Amsterdam Congress - 9th Y-ECCO Career Workshop : Session 2: Group session - Reviewing a scientific paper (Keywords: ECCO)
Authors: Laurence Egan
Last Modified: Monday, 3 July 2017, 1:30 PM by Carmen Sera
4th P-ECCO Educational Course Treat to target in paediatric IBD – same as in adults?
Year: 2017
Source: 4th P-ECCO Educational Course
Authors: van Rheenen P.
Last Modified: Wednesday, 15 March 2017, 1:35 PM by ECCO Administrator
Calprotectin, Colonoscopy, CRP, Disease activity indices, Patient reported outcomes, Paediatric, Treat to target
Files: 1
ECCO'17 BarcelonaTreating the pregnant woman with IBD: Should anti-TNF be stopped during pregnancy? Should vedolizumab be stopped during pregnancy?
Year: 2017
Source: ECCO'17 Barcelona
Authors: van der Woude J.
Last Modified: Wednesday, 15 March 2017, 2:01 PM by ECCO Administrator
Fertility, IBD and breastfeeding, IBD in pregnancy
Files: 1
ECCO'17 BarcelonaTrial endpoint vs. therapeutic objectives
Year: 2017
Source: ECCO'17 Barcelona
Authors: Baert F.
Last Modified: Wednesday, 15 March 2017, 4:55 PM by Vesna Babaja
Outcome measures, Patient reported outcomes, Histological remission, Disease activity indices, Mucosal healing
Files: 1
ECCO Talking HeadsUnder what circumstances can Faecal Calprotectin replace colonoscopy
Year: 2016
Source: ECCO Talking Heads
Authors: Edouard Louis, Patrick van Rheenen, Iris Dotan
Created: Friday, 17 March 2017, 9:50 AM by Vesna Babaja
ECCO Talking HeadsUnderstanding Cancer Risk in IBD Patients
Year: 2016
Source: ECCO Talking Heads
Authors: Tine Jess, Ebbe Langholz
Created: Friday, 17 March 2017, 9:28 AM by Vesna Babaja
15th IBD Intensive Advanced CourseUstekinumab
Year: 2017
Source: 15th IBD Intensive Advanced Course
Authors: Ferrante M.
Last Modified: Wednesday, 15 March 2017, 1:25 PM by Vesna Babaja
Crohn's disease, Disease activity Indices, Ustekinumab, Colonoscopy
Files: 1
15th IBD Intensive Advanced CourseVedolizumab
Year: 2017
Source: 15th IBD Intensive Advanced Course
Authors: Lindsay J.
Last Modified: Wednesday, 15 March 2017, 1:24 PM by Vesna Babaja
Therapeutic drug monitoring, Vedolizumab
Files: 1
4th P-ECCO Educational Course Vedolizumab in children and other biologics after TNF – what can we extrapolate? A case-based discussion
Year: 2017
Source: 4th P-ECCO Educational Course
Authors: Escher H.
Last Modified: Monday, 27 March 2017, 9:26 AM by Vesna Babaja
Ustekinumab, Vedolizumab, Paediatric
Files: 1
ECCO'18 ViennaWeb-based registries
Year: 2018
Source: ECCO'18 Vienna
Authors: Juillerat Pascal
Created: Friday, 23 March 2018, 12:23 PM
Files: 1
ECCO'18 ViennaWelcome
Year: 2018
Source: ECCO'18 Vienna
Authors: Schöfl Rainer
Created: Friday, 23 March 2018, 12:23 PM
Last Modified: Wednesday, 9 May 2018, 10:03 AM by Admin User
12th N-ECCO Network MeetingWelcome & Introduction
Year: 2018
Source: 12th N-ECCO Network Meeting
Authors: Bager Palle
Created: Friday, 23 March 2018, 12:23 PM
Files: 1
4th EpiCom WorkshopWelcome and Introduction
Year: 2018
Source: 4th EpiCom Workshop
Authors: Langholz Ebbe
Created: Friday, 23 March 2018, 12:23 PM
Files: 1
6th ClinCom WorkshopWelcome and introduction
Year: 2018
Source: 6th ClinCom Workshop
Authors: Ferrante Marc
Created: Friday, 23 March 2018, 12:23 PM
Files: 1
6th ClinCom WorkshopWhat is the value of retrospective CER?
Year: 2018
Source: 6th ClinCom Workshop
Authors: Hindryckx Pieter
Created: Friday, 23 March 2018, 12:23 PM
Files: 1
ECCO Talking HeadsWhen to stop biologics in IBD
Year: 2016
Source: ECCO Talking Heads
Authors: Javier Gisbert, Edouard Louis, John Mansfield
Created: Friday, 17 March 2017, 9:29 AM by Vesna Babaja
Page: () 1 2 3 4 5 6 7 8 9 10 ()